Table 2.

Crude association between IDH status and ADC value and morphologic features for the study set.

	Values	OR	P	95% CI
rADC	1.39 ± 0.39	0.05	<0.001	(0.01, 0.15)
ADCmin	1.02 ± 0.27	0.01	<0.001	(0.00, 0.07)
Age	45.30 ± 12.53	1.05	0.001	(1.02, 1.08)
Sex
Female	67 (38.07%)	Reference
Male	109 (61.93%)	0.76	0.372	(0.41, 1.39)
Tumor Location
Frontal lobe	89 (50.57%)	Reference
Other lobes	74 (42.05%)	2.63	0.003	(1.40, 4.97)
Thalamus or brainstem	9 (5.11%)	3.39	0.100	(0.80, 14.49)
Cerebellum	4 (2.27%)	5.09	0.166	(0.51, 50.97)
Diameter
<6 cm	132 (75.00%)	Reference
≥6 cm	44 (25.00%)	0.56	0.100	(0.28, 1.12)
Enhancement
Nonenhancement	63 (35.80%)	Reference
Patchy enhancement	42 (23.86%)	3.6	0.006	(1.44, 8.99)
Ring enhancement	71 (40.34%)	28.91	<0.001	(11.38,73.47)
Calcification
No	152 (86.36%)	Reference
Yes	24 (13.64%)	0.12	0.007	(0.03, 0.40)
Cystic Change
No	73 (41.48%)	Reference
Yes	103 (58.52%)	2.9	0.008	(1.56, 5.42)
Hemorrhage
No	91 (51.70%)	Reference
Yes	85 (48.30%)	5.11	<0.001	(2.69, 9.69)
T2-FLAIR Mismatch
No	136 (77.27%)	Reference
Yes	40 (22.73%)	0.4	0.017	(0.19, 0.85)